Updates in Surgery

, Volume 65, Issue 1, pp 53–57

Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention

  • Michele Ammendola
  • Valeria Zuccalà
  • Rosa Patruno
  • Emilio Russo
  • Maria Luposella
  • Andrea Amorosi
  • Giuseppina Vescio
  • Giuseppe Sammarco
  • Severino Montemurro
  • Giovambattista De Sarro
  • Rosario Sacco
  • Girolamo Ranieri
Original Article

Abstract

Literature data indicate that mast cells (MCs) are involved in angiogenesis through the release of several pro-angiogenetic factors among which tryptase, a serine protease stored in MC granules, is one of the most active. However, no data are available concerning the role of MCs during keloids’ angiogenesis. In this study, we evaluated the correlations of the number of MCs positive to tryptase (MCDPT) and microvascular density (MVD) within a series of 15 keloids and 10 normotrophic scars, by means of immunohistochemistry and image analysis methods. Data demonstrated a significant difference of MVD and MCDPT between keloids and normotrophic scars and a significant correlation between MVD and MCDPT in keloids. Our results suggest that tryptase-positive MCs might play a key role in keloids’ angiogenesis. In this context, several tryptase inhibitors might be clinically evaluated as a possible new anti-angiogenetic approach to prevent keloid formation after surgery.

Keywords

Angiogenesis Tryptase Mast cells Keloids Treatment 

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Michele Ammendola
    • 1
  • Valeria Zuccalà
    • 2
  • Rosa Patruno
    • 3
  • Emilio Russo
    • 4
  • Maria Luposella
    • 5
  • Andrea Amorosi
    • 2
  • Giuseppina Vescio
    • 1
  • Giuseppe Sammarco
    • 1
  • Severino Montemurro
    • 3
  • Giovambattista De Sarro
    • 4
  • Rosario Sacco
    • 1
  • Girolamo Ranieri
    • 6
  1. 1.Chair of Clinical SurgeryUniversity of Catanzaro “Magna Graecia” Medical SchoolCatanzaroItaly
  2. 2.Department of PathologyUniversity of Catanzaro Medical SchoolCatanzaroItaly
  3. 3.Surgery UnitNational Cancer Institute Giovanni Paolo IIBariItaly
  4. 4.Chair of Pharmacology, Department of Health ScienceUniversity of Catanzaro Medical SchoolCatanzaroItaly
  5. 5.Chair of Cardiovascular DiseaseUniversity of Catanzaro Medical SchoolCatanzaroItaly
  6. 6.Interventional Radiology Unit with Integrated Section of Medical Oncology, National Cancer Institute, Giovanni Paolo IIBariItaly

Personalised recommendations